Jonas Agnblad
Direktor/Vorstandsmitglied bei LEO Pharma A/S
Profil
Jonas Agnblad currently works at LEO Pharma A, as Director and Leo Pharma, Inc., as Director from 2021.
Mr. Agnblad also formerly worked at Acino International AG, as Director, The Binding Site Group Ltd., as Director, and NC Advisory AB, as Partner.
Mr. Agnblad received his graduate degree from Stockholm School of Economics.
Aktive Positionen von Jonas Agnblad
Unternehmen | Position | Beginn |
---|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Direktor/Vorstandsmitglied | - |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Direktor/Vorstandsmitglied | 01.01.2021 |
Ehemalige bekannte Positionen von Jonas Agnblad
Unternehmen | Position | Ende |
---|---|---|
ACINO HOLDING AG | Direktor/Vorstandsmitglied | - |
The Binding Site Group Ltd.
The Binding Site Group Ltd. Miscellaneous Commercial ServicesCommercial Services The Binding Site Group Ltd. engages in the development of medical equipment. It provides specialist diagnostic products to clinicians and laboratory professionals worldwide. Its products include freelite and hevylite; analysers and software; immunoassays; and manufacturing components. The company was founded by Jo Bradwell in 1983 and is headquartered in Birmingham, the United Kingdom. | Direktor/Vorstandsmitglied | - |
NC Advisory AB | Private Equity Investor | - |
Ausbildung von Jonas Agnblad
Stockholm School of Economics | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
NC Advisory AB | Finance |
Acino International AG
Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
The Binding Site Group Ltd.
The Binding Site Group Ltd. Miscellaneous Commercial ServicesCommercial Services The Binding Site Group Ltd. engages in the development of medical equipment. It provides specialist diagnostic products to clinicians and laboratory professionals worldwide. Its products include freelite and hevylite; analysers and software; immunoassays; and manufacturing components. The company was founded by Jo Bradwell in 1983 and is headquartered in Birmingham, the United Kingdom. | Commercial Services |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Retail Trade |